Axa Good Will vs Cash And Short Term Investments Analysis

EQH Stock

USD 39.64 0.21 0.53%

Axa Equitable financial indicator trend analysis is way more than just evaluating Axa Equitable Holdings prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Axa Equitable Holdings is a good investment. Please check the relationship between Axa Equitable Good Will and its Cash And Short Term Investments accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Axa Equitable Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.

Good Will vs Cash And Short Term Investments

Good Will vs Cash And Short Term Investments Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Axa Equitable Holdings Good Will account and Cash And Short Term Investments. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Axa Equitable's Good Will and Cash And Short Term Investments is -0.32. Overlapping area represents the amount of variation of Good Will that can explain the historical movement of Cash And Short Term Investments in the same time period over historical financial statements of Axa Equitable Holdings, assuming nothing else is changed. The correlation between historical values of Axa Equitable's Good Will and Cash And Short Term Investments is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Good Will of Axa Equitable Holdings are associated (or correlated) with its Cash And Short Term Investments. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash And Short Term Investments has no effect on the direction of Good Will i.e., Axa Equitable's Good Will and Cash And Short Term Investments go up and down completely randomly.

Correlation Coefficient

-0.32

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Good Will

An intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Axa Equitable Holdings balance sheet. This account contains Axa Equitable investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Axa Equitable Holdings fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most indicators from Axa Equitable's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Axa Equitable Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Axa Equitable Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.

As of now, Axa Equitable's Selling General Administrative is increasing as compared to previous years. The Axa Equitable's current Enterprise Value Over EBITDA is estimated to increase to 4.36, while Tax Provision is forecasted to increase to (718.2 M).

	2021	2022	2023	2024 (projected)
Gross Profit	6.6B	10.4B	6.3B	7.5B
Total Revenue	11.0B	12.6B	10.5B	9.3B

Gross Profit Total Revenue

Axa Equitable fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab
Common Stock Shares Outstanding		-0.86	0.64	-0.86	0.24	0.66	-0.91	0.66	0.6	0.44	-0.83	-0.13	-0.75	-0.66	-0.5	0.29	-0.1	-0.73	0.42	0.08	0.58	-0.66	-0.87	-0.79	0.99	-0.91
Total Assets	-0.86		-0.76	0.62	-0.4	-0.22	0.97	-0.22	-0.48	-0.25	0.94	-0.1	0.6	0.37	0.65	-0.08	0.08	0.67	-0.57	0.23	-0.3	0.44	0.82	0.79	-0.85	0.99
Short Long Term Debt Total	0.64	-0.76		-0.66	0.59	0.12	-0.7	0.11	0.57	-0.12	-0.65	0.2	-0.57	-0.38	-0.47	0.11	-0.06	-0.25	0.6	-0.07	0.21	-0.45	-0.72	-0.71	0.63	-0.74
Other Current Liab	-0.86	0.62	-0.66		-0.22	-0.75	0.68	-0.75	-0.78	-0.28	0.59	0.26	0.92	0.89	0.4	-0.26	0.2	0.48	-0.58	-0.47	-0.51	0.88	0.77	0.67	-0.86	0.67
Total Current Liabilities	0.24	-0.4	0.59	-0.22		-0.15	-0.27	-0.15	-0.03	-0.09	-0.15	0.62	0.02	0.17	-0.23	0.27	0.47	-0.12	0.31	-0.49	0.14	0.13	-0.35	-0.56	0.28	-0.37
Total Stockholder Equity	0.66	-0.22	0.12	-0.75	-0.15		-0.32	1.0	0.47	0.55	-0.23	-0.33	-0.64	-0.81	-0.05	0.35	-0.13	-0.47	0.13	0.58	0.57	-0.69	-0.4	-0.3	0.66	-0.31
Other Liab	-0.91	0.97	-0.7	0.68	-0.27	-0.32		-0.33	-0.52	-0.27	0.94	0.03	0.65	0.45	0.65	-0.1	0.08	0.75	-0.48	0.14	-0.39	0.51	0.87	0.82	-0.89	0.99
Net Tangible Assets	0.66	-0.22	0.11	-0.75	-0.15	1.0	-0.33		0.47	0.58	-0.23	-0.34	-0.65	-0.81	-0.13	0.35	-0.11	-0.51	0.14	0.59	0.58	-0.7	-0.39	-0.28	0.67	-0.31
Net Debt	0.6	-0.48	0.57	-0.78	-0.03	0.47	-0.52	0.47		0.35	-0.61	-0.64	-0.9	-0.82	-0.35	0.38	-0.68	-0.23	0.61	0.59	0.51	-0.89	-0.43	-0.27	0.64	-0.49
Retained Earnings	0.44	-0.25	-0.12	-0.28	-0.09	0.55	-0.27	0.58	0.35		-0.36	-0.42	-0.32	-0.36	-0.21	0.66	-0.29	-0.52	0.04	0.16	0.69	-0.33	0.03	0.05	0.54	-0.29
Accounts Payable	-0.83	0.94	-0.65	0.59	-0.15	-0.23	0.94	-0.23	-0.61	-0.36		0.18	0.64	0.43	0.53	-0.17	0.37	0.61	-0.51	0.11	-0.39	0.51	0.72	0.64	-0.82	0.94
Cash	-0.13	-0.1	0.2	0.26	0.62	-0.33	0.03	-0.34	-0.64	-0.42	0.18		0.45	0.51	0.02	-0.36	0.7	0.04	0.02	-0.63	-0.47	0.54	-0.07	-0.28	-0.16	-0.07
Non Current Assets Total	-0.75	0.6	-0.57	0.92	0.02	-0.64	0.65	-0.65	-0.9	-0.32	0.64	0.45		0.95	0.46	-0.13	0.48	0.42	-0.73	-0.63	-0.36	0.98	0.61	0.45	-0.76	0.62
Non Currrent Assets Other	-0.66	0.37	-0.38	0.89	0.17	-0.81	0.45	-0.81	-0.82	-0.36	0.43	0.51	0.95		0.27	-0.16	0.46	0.34	-0.57	-0.79	-0.39	0.98	0.48	0.31	-0.67	0.42
Other Assets	-0.5	0.65	-0.47	0.4	-0.23	-0.05	0.65	-0.13	-0.35	-0.21	0.53	0.02	0.46	0.27		0.12	-0.18	0.64	-0.49	0.04	-0.1	0.38	0.47	0.4	-0.55	0.63
Long Term Debt	0.29	-0.08	0.11	-0.26	0.27	0.35	-0.1	0.35	0.38	0.66	-0.17	-0.36	-0.13	-0.16	0.12		-0.21	-0.2	-0.17	0.01	0.91	-0.13	0.01	-0.08	0.38	-0.12
Cash And Short Term Investments	-0.1	0.08	-0.06	0.2	0.47	-0.13	0.08	-0.11	-0.68	-0.29	0.37	0.7	0.48	0.46	-0.18	-0.21		-0.23	-0.32	-0.5	-0.18	0.51	-0.11	-0.28	-0.12	0.06
Net Receivables	-0.73	0.67	-0.25	0.48	-0.12	-0.47	0.75	-0.51	-0.23	-0.52	0.61	0.04	0.42	0.34	0.64	-0.2	-0.23		-0.19	0.07	-0.49	0.35	0.56	0.62	-0.74	0.71
Good Will	0.42	-0.57	0.6	-0.58	0.31	0.13	-0.48	0.14	0.61	0.04	-0.51	0.02	-0.73	-0.57	-0.49	-0.17	-0.32	-0.19		0.33	-0.13	-0.68	-0.39	-0.36	0.45	-0.52
Short Term Investments	0.08	0.23	-0.07	-0.47	-0.49	0.58	0.14	0.59	0.59	0.16	0.11	-0.63	-0.63	-0.79	0.04	0.01	-0.5	0.07	0.33		0.1	-0.76	0.06	0.23	0.1	0.2
Long Term Debt Total	0.58	-0.3	0.21	-0.51	0.14	0.57	-0.39	0.58	0.51	0.69	-0.39	-0.47	-0.36	-0.39	-0.1	0.91	-0.18	-0.49	-0.13	0.1		-0.35	-0.31	-0.32	0.64	-0.37
Non Current Liabilities Total	-0.66	0.44	-0.45	0.88	0.13	-0.69	0.51	-0.7	-0.89	-0.33	0.51	0.54	0.98	0.98	0.38	-0.13	0.51	0.35	-0.68	-0.76	-0.35		0.5	0.32	-0.67	0.47
Capital Surpluse	-0.87	0.82	-0.72	0.77	-0.35	-0.4	0.87	-0.39	-0.43	0.03	0.72	-0.07	0.61	0.48	0.47	0.01	-0.11	0.56	-0.39	0.06	-0.31	0.5		0.92	-0.8	0.85
Other Current Assets	-0.79	0.79	-0.71	0.67	-0.56	-0.3	0.82	-0.28	-0.27	0.05	0.64	-0.28	0.45	0.31	0.4	-0.08	-0.28	0.62	-0.36	0.23	-0.32	0.32	0.92		-0.73	0.82
Other Stockholder Equity	0.99	-0.85	0.63	-0.86	0.28	0.66	-0.89	0.67	0.64	0.54	-0.82	-0.16	-0.76	-0.67	-0.55	0.38	-0.12	-0.74	0.45	0.1	0.64	-0.67	-0.8	-0.73		-0.89
Total Liab	-0.91	0.99	-0.74	0.67	-0.37	-0.31	0.99	-0.31	-0.49	-0.29	0.94	-0.07	0.62	0.42	0.63	-0.12	0.06	0.71	-0.52	0.2	-0.37	0.47	0.85	0.82	-0.89

Click cells to compare fundamentals

Axa Equitable Account Relationship Matchups

Axa Equitable fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	493.6M	450.4M	417.4M	379.9M	351.6M	391.5M
Total Assets	249.9B	282.3B	292.3B	252.7B	266.8B	271.6B
Short Long Term Debt Total	4.1B	4.1B	5.1B	5.2B	4.7B	4.0B
Other Current Liab	(2.1B)	(2.8B)	(2.8B)	(714M)	2.2B	2.3B
Total Current Liabilities	2.1B	2.8B	2.8B	3.0B	5.1B	2.8B
Total Stockholder Equity	13.5B	15.6B	11.5B	1.4B	2.6B	2.5B
Other Liab	215.6B	251.1B	272.3B	232.4B	267.3B	237.9B
Net Tangible Assets	7.7B	11.0B	5.2B	(3.4B)	(3.0B)	(2.9B)
Net Debt	(294M)	(2.1B)	(66M)	950M	(4.5B)	(4.2B)
Retained Earnings	11.8B	10.7B	8.9B	9.8B	10.2B	8.8B
Accounts Payable	2.1B	2.8B	2.7B	2.2B	2.7B	2.5B
Cash	4.4B	6.2B	5.2B	4.3B	9.1B	6.2B
Non Current Assets Total	79.5B	93.8B	88.2B	74.2B	243.3B	255.5B
Non Currrent Assets Other	(79.5B)	(93.8B)	(88.2B)	(1.2B)	227.7B	239.0B
Other Assets	159.4B	93.5B	181.6B	81.1B	147.3B	130.0B
Long Term Debt	6.4B	4.1B	5.0B	4.5B	5.4B	4.6B
Cash And Short Term Investments	4.4B	88.2B	5.2B	4.3B	75.3B	79.0B
Net Receivables	6.6B	6.8B	17.3B	11.6B	12.2B	10.2B
Good Will	4.6B	4.6B	4.6B	5.1B	4.6B	3.8B
Short Term Investments	66.3B	82.0B	79.9B	64.9B	1.5B	1.4B
Long Term Debt Total	6.4B	4.1B	3.9B	3.3B	3.0B	4.4B
Liabilities And Stockholders Equity	249.9B	282.3B	292.3B	252.7B	266.8B	271.6B
Non Current Liabilities Total	4.7B	4.9B	5.0B	3.3B	256.5B	269.3B
Capital Surpluse	1.9B	2.0B	1.9B	2.3B	2.6B	1.8B
Other Current Assets	14.2B	21.3B	27.6B	29.7B	23.5B	18.8B
Other Stockholder Equity	88M	(260M)	(931M)	(998M)	(1.4B)	(1.3B)
Total Liab	234.4B	265.0B	278.7B	249.1B	261.6B	257.4B
Deferred Long Term Liab	5.9B	749M	5.5B	8.2B	7.4B	4.5B
Long Term Investments	74.7B	109.1B	105.1B	93.1B	75.2B	84.7B
Short Long Term Debt	2.9B	546M	92M	759M	254M	241.3M
Total Current Assets	11.0B	95.0B	22.5B	97.4B	23.5B	42.2B
Accumulated Other Comprehensive Income	840M	3.9B	2.0B	(9.0B)	(7.8B)	(7.4B)
Short Term Debt	4.1B	4.1B	92M	759M	254M	241.3M
Intangible Assets	4.8B	4.7B	4.7B	5.5B	5.4B	4.5B
Cash And Equivalents	4.4B	6.2B	5.2B	4.3B	3.9B	4.0B
Net Invested Capital	16.9B	18.7B	15.1B	5.3B	6.7B	11.6B
Warrants	365M	143M	468M	455M	523.3M	356.0M
Noncontrolling Interest In Consolidated Entity	1.6B	1.6B	1.6B	1.7B	2.0B	1.8B
Retained Earnings Total Equity	11.8B	10.7B	8.9B	9.9B	8.9B	8.9B

Pair Trading with Axa Equitable

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axa Equitable position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axa Equitable will appreciate offsetting losses from the drop in the long position's value.

Moving together with Axa Stock

0.77	FIHL	Fidelis Insurance Report 28th of June 2024	Pair Corr
0.87	AEG	Aegon NV ADR	Pair Corr
0.85	AIG	American International Sell-off Trend	Pair Corr

Moving against Axa Stock

0.77

GSHD

Goosehead Insurance

Pair Corr

The ability to find closely correlated positions to Axa Equitable could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axa Equitable when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axa Equitable - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axa Equitable Holdings to buy it.

The correlation of Axa Equitable is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axa Equitable moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axa Equitable Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Axa Equitable can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Axa Equitable Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axa Equitable's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axa Equitable Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axa Equitable Holdings Stock:

How To Invest In Axa

Details

Is Axa Stock a good investment?

Details

What is Axa Equitable's Net Worth?

Details

Largest Diversified Financial Services Companies

View

Largest Insurance - Diversified Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Axa Equitable Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.

You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Axa Stock analysis

When running Axa Equitable's price analysis, check to measure Axa Equitable's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Axa Equitable is operating at the current time. Most of Axa Equitable's value examination focuses on studying past and present price action to predict the probability of Axa Equitable's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Axa Equitable's price. Additionally, you may evaluate how the addition of Axa Equitable to your portfolios can decrease your overall portfolio volatility.

	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Transaction History View history of all your transactions and understand their impact on performance

Is Axa Equitable's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axa Equitable. If investors know Axa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axa Equitable listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.33)

Dividend Share

0.9

Earnings Share

3.33

Revenue Per Share

30.362

Quarterly Revenue Growth

(0.05)

The market value of Axa Equitable Holdings is measured differently than its book value, which is the value of Axa that is recorded on the company's balance sheet. Investors also form their own opinion of Axa Equitable's value that differs from its market value or its book value, called intrinsic value, which is Axa Equitable's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axa Equitable's market value can be influenced by many factors that don't directly affect Axa Equitable's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Axa Equitable's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axa Equitable is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axa Equitable's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Axa Good Will vs Cash And Short Term Investments Analysis

Good Will vs Cash And Short Term Investments

Good Will vs Cash And Short Term Investments Correlation Analysis

Correlation Coefficient

Good Will

Cash And Short Term Investments

Axa Equitable fundamental ratios Correlations

Axa Equitable Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Axa Equitable fundamental ratios Accounts

Pair Trading with Axa Equitable

Moving together with Axa Stock

Moving against Axa Stock

Complementary Tools for Axa Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Tangible Assets	+ 1.0	Total Stockholder Equity
Other Stockholder Equity	+ 0.99	Common Stock Shares Outstanding
Total Liab	+ 0.99	Total Assets
Total Liab	+ 0.99	Other Liab
Non Current Liabilities Total	+ 0.98	Non Current Assets Total
Non Current Liabilities Total	+ 0.98	Non Currrent Assets Other

Total Liab	- 0.91	Common Stock Shares Outstanding
Other Liab	- 0.91	Common Stock Shares Outstanding
Non Current Assets Total	- 0.9	Net Debt
Total Liab	- 0.89	Other Stockholder Equity
Non Current Liabilities Total	- 0.89	Net Debt
Other Stockholder Equity	- 0.89	Other Liab